Titre:
  • Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
Auteur:Marin-Bejar, Oskar; Rogiers, Aljosja; Dewaele, Michael; Femel, Julia; Karras, Panagiotis; Pozniak, Joanna; Bervoets, Greet; Van Raemdonck, Nina; Pedri, Dennis; Swings, Toon; Demeulemeester, Jonas; Borght, Sara Vander; Lehnert, Stefan; Bosisio, Francesca; van den Oord, Joost; Vanden Bempt, Isabelle; Lambrechts, Diether; Voet, T.; Bechter, Oliver; Rizos, Helen; Levesque, Mitchell Paul; Leucci, Eleonora; Lund, Amanda A.W.; Rambow, Florian; Marine, Jean-Christophe
Informations sur la publication:Cancer cell, 39, 8, page (1135-1149.e8)
Statut de publication:Publié, 2021-08-01
Sujet CREF:Biologie cellulaire
Cancérologie
Mots-clés:cutaneous melanoma
FAK signaling
minimal residual disease
neural crest stem cells
nongenetic reprogramming
patient-derived tumor xenografts
single-cell sequencing
therapy resistance
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1535-6108
info:doi/10.1016/j.ccell.2021.05.015
info:pii/S1535610821002816
info:scp/85111911289
info:pmid/34143978